about
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tr...
Read More
1.16
0.04
(3.57%)
317.6K
XNAS Volume
XNAS 10 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for RenovoRx Inc is on 14 Aug 2026 for the purpose of RenovoRx Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
RenovoRx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..